Sugi Predict

Sugi Predict / Targets / RO60

RO60

RNA-binding protein RO60 · P10155 · RO60 on Sugi Atlas →

0 patent compounds predicted against RO60, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RO60 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Anti-CD20 Antibodies for Treatment of SLE-PAH PHASE4UNKNOWN
Myositis Interstitial Lung Disease Nintedanib Trial PHASE4COMPLETED
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) PHASE3RECRUITING
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD) PHASE2/PHASE3RECRUITING
Belimumab in Idiopathic Inflammatory Myositis PHASE2/PHASE3COMPLETED
Preventive Approach to Congenital Heart Block With Hydroxychloroquine PHASE2COMPLETED
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS) PHASE2WITHDRAWN
A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax PHASE1COMPLETED
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy PHASE1COMPLETED
Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA) PHASE1COMPLETED
A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body PHASE1NOT_YET_RECRUITING
GC012F Injection in Refractory Idiopathic Inflammatory Myopathy EARLY_PHASE1RECRUITING
Ro60 Expression in Macrophages in Sjogren's Disease nanACTIVE_NOT_RECRUITING
Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification (Ro-SjS) nanNOT_YET_RECRUITING
The Clinical Course of Interstitial Pneumonia With Autoimmune Features nanCOMPLETED
Follow-up Study of Individuals with Autoantibodies Against Ro/SSA and La/SSB nanRECRUITING
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Clinical Performance of BioCLIA Ro60 nanWITHDRAWN
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage nanUNKNOWN
Prognostic Value of Anti-Ro52 Antibodies in Connective Tissue Diseases (a-Ro52) nanUNKNOWN
Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies nanUNKNOWN
Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease. nanCOMPLETED
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity nanRECRUITING
(Anti-Ribosomal P Protein,Anti-U1 RNP, Anti-Nucleosome and Anti-ds DNA Antibodies) and Relation to Depression and Anxiety in SLE nanUNKNOWN
Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases nanRECRUITING
Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD) nanUNKNOWN
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome nanCOMPLETED
Multi-Dimensional Genomic Dissection of Ring Chromosome 14 Syndrome nanACTIVE_NOT_RECRUITING
T1D Risk Assessment in Kids With Relatives nanCOMPLETED
The Genetic and the Functional Study of DNA Repair System and the Susceptibility to Rheumatoid Arthritis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RO60 binder may also engage these)

ProteinNameSimilarity
O08848 — 0.992 O08848 →
Q4R4U1 — 0.965 Q4R4U1 →
Q923S8 — 0.964 Q923S8 →
Q6DFV5 — 0.964 Q6DFV5 →
HELZ Probable helicase with zinc finger domain 0.963 landscape →
ACACA Acetyl-CoA carboxylase 1 0.960 landscape →
Q5SWU9 — 0.960 Q5SWU9 →
Q5R5F8 — 0.959 Q5R5F8 →
Q7L5D6 — 0.958 Q7L5D6 →
Q6NYU2 — 0.958 Q6NYU2 →
Q6TV19 — 0.958 Q6TV19 →
HAT1 Histone acetyltransferase type B catalytic subunit 0.958 landscape →
A4QNE0 — 0.957 A4QNE0 →
Q9NVE7 — 0.957 Q9NVE7 →
Q6TUI4 — 0.957 Q6TUI4 →
Q8R418 — 0.957 Q8R418 →
Q80YV4 — 0.955 Q80YV4 →
P11497 — 0.955 P11497 →
Q9D1H7 — 0.954 Q9D1H7 →
Q28559 — 0.954 Q28559 →
Q9TTS3 — 0.954 Q9TTS3 →
Q8IZD9 — 0.953 Q8IZD9 →
Q6DC64 — 0.953 Q6DC64 →
A0MQH0 — 0.953 A0MQH0 →
A0A8J1LLF7 — 0.952 A0A8J1LLF7 →
Q8BHL5 — 0.952 Q8BHL5 →
A0A974H8H3 — 0.951 A0A974H8H3 →
Q8CIQ7 — 0.951 Q8CIQ7 →
Q6NRL4 — 0.951 Q6NRL4 →
Q8BY71 — 0.951 Q8BY71 →